Head & Neck/Thyroid Cancers
From the Journals
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Feature
Conducting cancer trials amid the COVID-19 pandemic
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center
Feature
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
From the Journals
Blood test might detect multiple cancer types, study suggests
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based...
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?